Bottom Line: In patients with Alzheimer disease (AD), increased cerebrospinal fluid levels of orexin, which helps regulate the sleep-wake cycle, may be associated with sleep deterioration, which appears to be associated with cognitive decline.
Authors: Claudio Liguori, M.D., of the University of Rome Tor Vergata, Italy, and colleagues.